PHOTANOL BV

Their core work

Photanol is a Dutch biotech SME that uses engineered cyanobacteria to convert CO2 and sunlight directly into valuable chemicals, most notably lactic acid for bioplastic (PLA) production. Their core technology bypasses traditional biomass feedstocks entirely — instead of fermenting sugars from crops, they program photosynthetic microorganisms to produce industrial chemicals from carbon dioxide. This positions them at the intersection of industrial biotechnology, sustainable plastics, and carbon capture utilization, offering a genuinely different route to bio-based materials.

What they specialise in

How they've shifted over time

Photanol's early H2020 work (2018) was broader in scope — ENGICOIN explored multiple CO2-derived products including hydrogen, PHA, acetone, and lactic acid as part of a larger waste treatment platform. By 2019, they sharpened their focus dramatically: RePLAy zeroed in on a single high-value product chain — CO2 to lactic acid to PLA bioplastic — with clear commercial applications in packaging. This narrowing from multi-product exploration to a specific market-ready value chain (bioplastic/packaging) signals a company moving from R&D diversification toward commercialization.

Photanol is converging on the CO2-to-PLA bioplastic value chain with packaging as the target market, suggesting they are positioning for commercial scale-up rather than further basic research.

How they like to work

Photanol predominantly leads its projects — coordinating 2 out of 3 H2020 projects, including their largest (RePLAy, EUR 2.26M). They work with moderately sized consortia (13 unique partners across 7 countries), which is substantial for a biotech SME with only 3 projects. This suggests a company confident in driving its own R&D agenda while building a broad European network, making them a strong potential lead partner for consortia in bio-based chemicals.

Photanol has built a network of 13 partners across 7 countries in just 3 projects, indicating they actively seek diverse European collaboration rather than relying on a small circle of repeat partners. Their Amsterdam base connects them to the strong Dutch biotech and chemicals ecosystem.

What sets them apart

Photanol occupies a rare niche: direct photosynthetic conversion of CO2 into industrial chemicals using engineered cyanobacteria, bypassing the need for agricultural feedstocks entirely. This is fundamentally different from conventional bio-based plastic companies that rely on sugar fermentation. For potential partners, this means access to a genuinely distinct technology platform that addresses both carbon utilization and sustainable materials in one step — particularly relevant as the EU tightens regulations on single-use plastics and carbon emissions.

Highlights from their portfolio

• RePLAy
  Their flagship project (EUR 2.26M, coordinator) targeting the full CO2-to-PLA bioplastic chain — the clearest signal of their commercial direction and largest funding by far.
• ENGICOIN
  Broader CO2 exploitation platform producing multiple chemicals (lactic acid, PHA, hydrogen, acetone), demonstrating the versatility of their microbial engineering approach beyond just PLA.